학술논문

Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients
Document Type
Article
Source
In: European Journal of Gastroenterology and Hepatology. (European Journal of Gastroenterology and Hepatology, 1 May 2021, 33(5):670-679)
Subject
Language
English
ISSN
14735687
0954691X